Pharmaceutical methods, compositions and combinations
AssigneeRegents of the University of Minnesota
InventorsDarko Bosnakovski, Erdong Wei
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating cancer in an animal in need thereof, comprising administering to the animal a p300/CBP (p300 and/or CBP) modulator or a pharmaceutically acceptable salt thereof and a senotherapeutic (e.g., a senolytic or senomorphic) or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions and pharmaceutical combinations, comprising a p300/CBP (p300 and/or CBP) modulator or a pharmaceutically acceptable salt thereof and a senotherapeutic (e.g., a senolytic or senomorphic) or a pharmaceutically acceptable salt thereof.
Claims19
A method for treating cancer in an animal in need thereof, comprising administering (e.g., co-administering) to the animal a p300/CBP (p300 and/or CBP) modulator or a pharmaceutically acceptable salt thereof and a senotherapeutic (e.g., a senolytic or senomorphic) or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition or pharmaceutical combination, comprising a p300/CBP (p300 and/or CBP) modulator or a pharmaceutically acceptable salt thereof and a senotherapeutic (e.g., a senolytic or senomorphic) or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition or pharmaceutical combination comprising a p300/CBP (p300 and/or CBP) modulator or a pharmaceutically acceptable salt thereof and a senotherapeutic (e.g., a senolytic or senomorphic) or a pharmaceutically acceptable salt thereof for medical treatment.
The use of a pharmaceutical composition or pharmaceutical combination comprising a p300/CBP (p300 and/or CBP) modulator or a pharmaceutically acceptable salt thereof and a senotherapeutic (e.g., a senolytic or senomorphic) or a pharmaceutically acceptable salt thereof for the treatment of cancer.
(canceled)
Dependencies are inferred from the claim text.